REFERENCES

[1] Truszczynski, M 2011, 'Q fever', Medycyna Weterynaryjna, vol. 67, no 1, pp. 15-19.

 

[2] Jackson, DA 2005, 'Q fever update', Australian Veterinary Journal, vol. 83, no. 12, pp. 706-706.

 

[3] Maurin, M & Raoult, DF 1999, 'Q fever', Clinical Microbiology Reviews, vol. 12, no. 4, pp. 518-553.

 

[4] Angelakis, E & Raoult, D 2010, 'Q fever', Veterinary Microbiology, vol. 140, no. 3-4, pp. 297-309.

 

[5] Sellens, E, Norris, JM, Dhand, NK, Heller, J, Hayes, L, Gidding, HF, Willaby, H, Wood, N & Bosward, KL 2016, ‘Q Fever Knowledge, Attitudes and Vaccination Status of Australia’s Veterinary Workforce in 2014’, PLoS ONE, vol. 11, no. 1, pp. 1-18.

​

[6] Sellens, E, Norris, JM, Dhand, NK, Heller, J, Hayes, L, Gidding, HF, Willaby, H, Wood, N & Bosward, KL 2018, ‘Willingness of veterinarians in Australia to recommend Q fever vaccination in veterinary personnel: Implications for workplace health and safety compliance’, PLoS ONE, vol. 13, no. 6, pp. 1-15.

​

[7] Q fever – are you at risk?? 2018, video recording, Wangaratta Veterinary Clinic, Victoria, viewed 26 October 2018, <https://www.facebook.com/wangarattavetclinic/videos/1739121829506712/>.

​

[8] Houpikian, P, Habib, G, Mesana, T & Raoult, D 2002, 'Changing clinical presentation of Q fever endocarditis', Clinical Infectious Diseases, vol. 34, no. 5, pp. e28-e31.

​

[9] Raoult, D, Tissot-Dupont, H, Foucault, C, Gouvernet, J, Fournier, PE, Bernit, E, Stein, A, Nesri, M, Harle, JR & Weiller, PJ 2000, 'Q fever 1985-1998: Clinical and epidemiologic features of 1,383 infections', Medicine (Baltimore), vol. 79, no. 2, pp. 109-123.

 

[10] Tissot-Dupont, H & Raoult, D 2008, 'Q fever', Infectious disease clinics of North America, vol. 22, no. 3, pp. 505-514.

 

[11] Moffatt, JH, Newtown, P & Newtown, HJ 2015, 'Coxiella burnetii: turning hostility into a home', Cellular Microbiology, vol. 12, no. 5, pp. 621-631.

 

[12] Woldehiwet, Z 2004, 'Q fever (coxiellosis): epidemiology and pathogenesis', Research in Veterinary Science, vol. 77, no. 2, pp. 93-100.  

 

[13] Van Schaik, EJ, Chen, C, Mertens, K, Weber, MW & Samuel, JE 2013, ‘Molecular pathogenesis of the obligate intracellular bacterium Coxiella burnetii’, Nature Reviews, Microbiology, vol. 11, no. 8, pp. 561-573.

 

[14] NSW Health 2018, Q Fever Vaccination Fact Sheet, NSW Government, Sydney, viewed 26 October 2018, <https://www.health.nsw.gov.au/Infectious/factsheets/Pages/q-fever-vaccine.aspx>.

 

[15] Martinov, SP 2017, Q fever, River Publishers, Gistrup, Denmark.

 

[16] Van Roeden, S, Bleeker-Rovers, C, de Regt, M, Kampschreur, L, Hoepelman, A, Wever, P and Oosterheert, J 2018, ‘Treatment of Chronic Q Fever; Clinical Efficacy and Toxicity of Antibiotic Regimens’, Clinical Infectious Diseases, vol. 66, no. 5, pp. 719-726.

 

[17] Clay, K, Hartley, M, Russell, P & Norville, I 2018, ‘Use of axenic media to determine antibiotic efficacy against Coxiella burnettii, International Journal of Antimicrobial Agents, vol. 51, no. 5, pp 806-808.

 

[18] Keijmel, S, Delsing, C, Bleijenberg, G, van der Meer, J, Donders, R, Leclercq, M, Kampschreur, L, van den Berg, M, Sprong, T, Nabuurs-Franssen, M, Knnop, H & Bleeker-Rovers, C 2017, ‘Effectiveness of Long-term Doxycycline Treatment and Cognitive-Behavioural Therapy on Fatigue Severity in Patients with Q Fever Fatigue Syndrome (Qure study): A Randomized Controlled Trial’, Clinical Infectious Diseases, vol. 64, no. 8, pp. 998-1005.

 

[19] Seqirus 2018, Q-Vax Consumer Medicine Information, Seqirus Australia, Victoria, viewed 26 October 2018, <https://www.seqirus.com.au/docs/314/728/Q-vax%20CMI%2024Oct%202017.pdf>.

​

[20] NSW Health 2018, Q Fever and Veterinary Staff, NSW Government, Sydney, viewed 26 October 2018, <https://www.health.nsw.gov.au/Infectious/factsheets/Pages/q-fever-veterinary-staff.aspx>.

​​

​[21] Australian Meat Processor Corporation 2018, Q Fever Register, Australian Meat Processor Corporation, Sydney, viewed 26 October 2018, <https://www.qfever.org>.